Use of an antigenic peptide derived from isolated s100-beta protein not bound to a MHC class II molecule in the prevention, treatment, diagnosis and / or monitoring of diabetes type i

摘要

Use of an antigenic peptide isolated protein derivative S100-beta not bound to a MHC class II molecule in the prevention, treatment, diagnosis and / or monitoring of type I diabetes # The present invention relates to the use of a peptide isolated antigenic derivative S100-beta protein that is not bound to a MHC class II molecule in the manufacture of a medicament for the prevention, treatment, diagnosis and / or monitoring of type I diabetes